RTS Life Science, a worldwide supplier of automated sample management and pharmaceutical testing systems, has announced their new US headquarters and the formation of "RTS Life Science LLC".
Olympus recently earned two awards at the first European Scanner Contest, which took place in Berlin in conjunction with the 94th Annual Meeting of the German Society of Pathology and the 10th Pathology Federal Meeting.
In one of the first efforts of its kind, researchers have taken mammalian genome maps, including human maps, one step further by showing not just the order in which genes fall in the genome but which genes actually interact.
A kinase is a type of enzyme the body uses to regulate the functions of the proteins required for cell growth and maintenance, and researchers have discovered that one in particular plays a key role in developing prostate cancer.
Amarin Corporation plc, a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, announced that its MARINE trial, a Phase 3 clinical trial of AMR101, has completed patient enrollment and randomization into the treatment phase of this trial.
Vertex Pharmaceuticals Inc. said that a study showed some patients who take its hepatitis C drug candidate telaprevir may be able to complete their treatment sooner.
Scientists from UCLA's California NanoSystems Institute and Korea's Yonsei University have developed an innovative method that enables nanomachines to release drugs inside living cancer cells when activated remotely by an oscillating magnetic field.
Teva Pharmaceutical has solidified operations further in Europe, announcing that it completed a $4.95 billion buyout of German drugmaker Ratiopharm.
Doctors can't tell if Leif Utoft Bollesen's mild memory loss will remain an annoyance or worsen, but experimental checks of the Minnesota man's aging brain may offer clues.
The World Health Organization has declared the swine flu pandemic officially over, months after many national authorities started canceling vaccine orders and shutting down hot lines as the disease ebbed from the headlines.
Merck, the world's second-biggest drugmaker by revenue, has received inquiry letters from both the Department of Justice and the Securities and Exchange Commission seeking information about activities in a number of countries and reference the Foreign Corrupt Practices Act.
A unique clinical development program speeds Phase 3 trials.
Qlucore Omics Explorer enables scientists to analyse very large data sets using combination of statistical methods and visualization techniques, without having to be a statistics or computer expert.
Scientists at the Dana-Farber Cancer Institute—one of the leading cancer research and care centers in the United States—have pioneered a new approach to manage the massive amount of data needed to accelerate medical research.